65 results
424B5
PRTG
Portage Biotech Inc
2 Oct 23
Prospectus supplement for primary offering
6:01pm
products Regulatory Agency in the United Kingdom and Research Ethics Board at Oxford University. When COVID restrictions ease in the United Kingdom … and institution ethics approval. The combination product has the ability to prime and boost an anti-tumor immune response.
Biodegradable PLGA
6-K
EX-2.1
gxqtrk
8 Jul 22
Current report (foreign)
8:58am
6-K
EX-99.2
5n2k9kkbe
25 Feb 22
Current report (foreign)
5:29pm
6-K
EX-99.2
7yli ehads
23 Nov 21
Current report (foreign)
4:30pm
6-K
EX-99.2
qb7kpwm
30 Aug 21
Current report (foreign)
5:21pm
SUPPL
ckh6 b6s8b
24 Jun 21
Supplemental materials (foreign)
5:27pm
SUPPL
yyfgp
23 Jun 21
Supplemental materials (foreign)
4:01pm
424B2
k4p5a4o aqmsdebp4xi
8 Mar 21
Prospectus for primary offering
5:00pm
6-K
EX-99.2
8inh7hexcht0ycrwy
1 Mar 21
Condensed Consolidated Interim Financial Statements
4:23pm
F-3
z96p 3qwownj
24 Feb 21
Shelf registration (foreign)
5:22pm
6-K
EX-99.1
1weoitl6
11 Feb 21
Portage Biotech Provides Research and Development Update and Announces Nasdaq Listing Approval
4:30pm
6-K
EX-99.1
z2u4 hcv4yc8evkj
28 May 20
Report of Foreign Private Issuer
12:19pm
6-K
EX-99.1
j4pa2 dar
19 Feb 19
Report of Foreign Private Issuer
10:37am